Common use

Cyklokapron tablets contain tranexamic acid, a powerful antifibrinolytic medication specifically designed for hemorrhage control and the management of excessive bleeding conditions. This medication is most widely prescribed for heavy menstrual bleeding (menorrhagia), a condition that affects millions of women worldwide and can significantly impact quality of life, energy levels, and daily functioning. Clinical studies demonstrate that Cyklokapron can reduce menstrual blood loss by up to 58 percent, making it one of the most effective treatments available for this common bleeding disorder.

When you buy Cyklokapron online, you access a trusted antifibrinolytic medication that works by stabilizing blood clots and preventing their premature breakdown. Tranexamic acid achieves this by blocking the action of plasmin, the enzyme responsible for dissolving blood clots (fibrinolysis). Beyond menorrhagia treatment, Cyklokapron is effectively used for hemorrhage control in a variety of clinical situations, including post-surgical bleeding (particularly after dental and bladder procedures), persistent nosebleeds (epistaxis), and other conditions where excessive bleeding must be controlled quickly and safely. Cyklokapron generic versions containing the same tranexamic acid formulation provide identical therapeutic benefits, making it affordable to buy tranexamic acid for both acute and recurrent bleeding episodes.



Dosage and direction

Cyklokapron should be taken orally regardless of meals, though swallowing the tablets with a full glass of water aids absorption and minimizes potential gastrointestinal discomfort. Your doctor will determine the optimal dosage based on your specific bleeding disorder and clinical needs. The standard adult dosage for heavy menstrual bleeding is typically 2 tablets (1000 mg of tranexamic acid) taken 3 times daily during your menstrual period.

Tablets must be swallowed whole — never crush, break, or chew them, as this affects the controlled release of the antifibrinolytic medication. For menorrhagia treatment, Cyklokapron should not be taken for more than 5 consecutive days per menstrual cycle. Treatment should begin when heavy bleeding starts and continue for the duration of the heaviest flow days. If your heavy menstrual bleeding does not improve after several cycles of tranexamic acid therapy, consult your healthcare provider for further evaluation and possible alternative treatment approaches.



Precautions

Any visual disturbances that develop during Cyklokapron therapy — including changes in color vision, blurred vision, or other eye-related symptoms — must be reported to your healthcare provider immediately and may require discontinuation of the antifibrinolytic medication. Patients using tranexamic acid for extended periods should undergo regular professional eye examinations and routine blood tests to monitor for potential complications.

Cyklokapron must be used with particular caution in the following circumstances: girls under the age of 15, patients with decreased kidney function (dose adjustment may be necessary), individuals with an elevated risk of blood clotting (thrombosis), and those with medical conditions that affect normal blood clotting mechanisms. Maintain regular follow-up appointments with your doctor throughout your hemorrhage control therapy. If you plan to buy Cyklokapron online for recurrent menorrhagia, establish ongoing medical supervision to ensure safe long-term use.



Contraindications

Patients with severe kidney failure must not use Cyklokapron, as impaired renal clearance can lead to dangerous accumulation of tranexamic acid. Individuals with a history of or current thromboembolic disease (blood clots in blood vessels) — including deep vein thrombosis, pulmonary embolism, or stroke — are strictly contraindicated from using this antifibrinolytic medication. Never take Cyklokapron if you are allergic to tranexamic acid or any other ingredient in the formulation. Contact your physician or pharmacist immediately if you experience any signs of allergic reaction, including skin rash, itching, facial swelling, or difficulty breathing.



Possible side effect

Side effects from Cyklokapron therapy can vary among individuals. Common adverse reactions associated with this bleeding disorder treatment include: diarrhea, nausea, and vomiting. These gastrointestinal effects are typically mild and often resolve as your body adjusts to the tranexamic acid medication.

Less common but more serious side effects may include: allergic responses such as skin itching, redness, or swelling; visual disturbances including changes in color perception; and, rarely, thromboembolic events (blood clots). The risk of blood clotting complications is the most clinically significant concern with antifibrinolytic therapy. If you experience sudden leg pain or swelling, chest pain, shortness of breath, severe headache, or visual changes during menorrhagia treatment, seek emergency medical attention immediately, as these may indicate a serious blood clotting event.



Drug interaction

Cyklokapron may interact with several medications and substances that affect blood clotting. Inform your doctor about all medications you are taking, including herbal remedies and over-the-counter products. The following thrombolytic medications must not be used concurrently with this antifibrinolytic: alteplase, reteplase, streptokinase, tenecteplase, and urokinase — as these drugs work by dissolving blood clots, directly opposing the hemorrhage control mechanism of tranexamic acid. Hormonal contraceptives containing estrogen may increase the risk of thromboembolic events when combined with Cyklokapron. Discuss all potential interactions with your healthcare provider before starting treatment.



Missed dose

Do not attempt to double up on missed doses of Cyklokapron. If you miss a scheduled dose, take the next one as soon as you remember, then resume your regular dosing schedule. A doubled dose of this antifibrinolytic can increase the risk of adverse effects. If you are unsure about how to handle a missed dose during your heavy menstrual bleeding treatment, contact your doctor or pharmacist for guidance on rescheduling your tranexamic acid doses.



Overdose

Taking more than 3 doses (6 tablets, or 3000 mg of tranexamic acid) within a 24-hour period may constitute an overdose. The most commonly reported symptoms of Cyklokapron overdose include visual disturbances, changes in color perception, and potential thromboembolic complications. If you suspect you have taken too much of this bleeding disorder medication, contact your doctor or emergency medical services immediately. Do not wait for symptoms to appear — prompt medical evaluation is important for preventing potential complications from antifibrinolytic overdose.



Storage

Keep Cyklokapron away from children and household pets. Store the tranexamic acid tablets in a cool, clean, dry place protected from constant heat, direct sunlight, and moisture. Maintain storage temperature below 30°C (86°F). Keep the antifibrinolytic medication in its original packaging until use and properly dispose of any expired tablets.



Disclaimer

We provide only general information about medications which does not cover all directions, possible drug integrations, or precautions. Information at the site cannot be used for self-treatment and self-diagnosis. Any specific instructions for a particular patient should be agreed with your health care adviser or doctor in charge of the case. We disclaim reliability of this information and mistakes it could contain. We are not responsible for any direct, indirect, special or other indirect damage as a result of any use of the information on this site and also for consequences of self-treatment.